Kezar Life Sciences, Inc. financial data

Symbol
KZR on Nasdaq
Location
4000 Shoreline Court, Suite 300, South San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 703 % -29.6%
Debt-to-equity 20.8 % +8.45%
Return On Equity -62.5 % -4.69%
Return On Assets -51.8 % -3.29%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.32M shares +0.37%
Common Stock, Shares, Outstanding 7.32M shares +0.37%
Entity Public Float 43M USD -75.1%
Common Stock, Value, Issued 7K USD 0%
Weighted Average Number of Shares Outstanding, Basic 7.32M shares +0.37%
Weighted Average Number of Shares Outstanding, Diluted 7.32M shares +0.37%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 44.7M USD -38.2%
General and Administrative Expense 20.8M USD -11.8%
Operating Income (Loss) -65.5M USD +36.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -61.7M USD +35.6%
Earnings Per Share, Basic -8 USD/shares +55.4%
Earnings Per Share, Diluted -8 USD/shares +55.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 38.9M USD +11.7%
Marketable Securities, Current 51.3M USD -54.8%
Accounts Receivable, after Allowance for Credit Loss, Current 7M USD
Other Assets, Current 935K USD +14.3%
Assets, Current 94.5M USD -39.6%
Property, Plant and Equipment, Net 2.18M USD -30.9%
Operating Lease, Right-of-Use Asset 1.05M USD -51%
Other Assets, Noncurrent 0 USD -100%
Assets 97.7M USD -40.4%
Accounts Payable, Current 911K USD -73.7%
Employee-related Liabilities, Current 2.12M USD -0.24%
Accrued Liabilities, Current 3.93M USD -59.4%
Liabilities, Current 13.4M USD -34.5%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 14.8M USD -50.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 14K USD -86.9%
Retained Earnings (Accumulated Deficit) -476M USD -14.9%
Stockholders' Equity Attributable to Parent 83M USD -38.1%
Liabilities and Equity 97.7M USD -40.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.2M USD +24.8%
Net Cash Provided by (Used in) Financing Activities -1.3M USD
Net Cash Provided by (Used in) Investing Activities 13.7M USD -32.7%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 7.32M shares +0.37%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.75M USD -92.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 38.9M USD +11.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 189K USD -43.8%
Deferred Tax Assets, Valuation Allowance 102M USD +24.2%
Deferred Tax Assets, Gross 103M USD +23.1%
Operating Lease, Liability 3.26M USD -51%
Depreciation 800K USD -33.3%
Payments to Acquire Property, Plant, and Equipment 8K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -61.8M USD +34.9%
Lessee, Operating Lease, Liability, to be Paid 3.44M USD -53.7%
Property, Plant and Equipment, Gross 9.32M USD -0.3%
Operating Lease, Liability, Current 3.26M USD -3.89%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.42M USD -39.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 347K USD -91.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 178K USD -77.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 347K USD -91.5%
Deferred Tax Assets, Operating Loss Carryforwards 50.3M USD +17.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 5.01M USD +22.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 347K USD +23.1%
Operating Lease, Payments 3.39M USD +17.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 251K USD -3.46%
Deferred Tax Assets, Net of Valuation Allowance 659K USD -48.4%
Share-based Payment Arrangement, Expense 10.6M USD -17.6%
Interest Expense 1.6M USD +6.87%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%